Biogaia

Biogaia Forward P/E

The Forward P/E Ratio of Biogaia (BIOG B.ST) as of Nov 11, 2026 is 31.85. In the previous year, Forward P/E Ratio was 30.16 — a change of 5.60% (higher).

Forward P/E

31.85

YoY

5.60%

Last updated:

Forward P/E Ratio of Biogaia is 2025 31.85 . Forward P/E Ratio of Biogaia was 2024 30.16 . It decreases by 5.60% higher compared to the previous year.

The Biogaia Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
49.32 SEK
Jan 1, 2019
56.57 SEK
Jan 1, 2020
58.97 SEK
Jan 1, 2021
54.00 SEK
Jan 1, 2022
28.35 SEK
Jan 1, 2023
29.01 SEK
Jan 1, 2024
30.16 SEK
Jan 1, 2025
31.85 SEK
The Biogaia Forward P/E history
YEARForward P/EYoY
31.85+5.60%
30.16+3.97%
29.01+2.30%
28.35-47.49%
54.00-8.43%
58.97+4.24%
56.57+14.70%
49.32-15.97%
58.69+26.03%
46.57-46.65%
87.29+21.41%
71.90—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

Forward P/E Ratio of Biogaia is 31.85 in 2025.

Forward P/E Ratio of Biogaia changed from 30.16 to 31.85, representing a 5.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Biogaia since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Biogaia with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Biogaia

All Key Metrics — Biogaia